Optimization of culture conditions of Bacillus subtilis with α-glucosidase inhibitory activity
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
1-Deoxynojirimycin (DNJ) have been extensively investigated for their α-glucosidase inhibitor on postprandial hyperglycemia, and applied in nutraceuticals and medicine for preventing or delaying progression of type 2 diabetes. However, the amount of DNJ in mulberry leaves is low (about 0.1%), therefore, more effective extraction method is needed. This study was performed to develop microbial DNJ for biological methods of DNJ as an alternative to the chemical methods. In this study, we obtained evidence for Bacillus subtilis that produce DNJ in large quantities by high performance liquid chromatography. Inhibition of α-glucosidase activity was determined to DNJ production or non-production. Investigation of the effect of mulberry leaves powder concentration (1~5%), using the DNJ high-production bacteria, provided evidence for microbial mass production of DNJ. When the 4% mulberry leaf powder for 9 days was used, the α-glucosidase inhibitory activity was over the 85%. Also, the results presented in this study confirm DNJ yield’s increasement in microbes using the various of nutrients and provide insight of ways to improve DNJ yields in microorganisms.
Abstract
1-Deoxynojirimycin (DNJ) have been extensively investigated for their α-glucosidase inhibitor on postprandial hyperglycemia, and applied in nutraceuticals and medicine for preventing or delaying progression of type 2 diabetes. However, the amount of DNJ in mulberry leaves is low (about 0.1%), therefore, more effective extraction method is needed. This study was performed to develop microbial DNJ for biological methods of DNJ as an alternative to the chemical methods. In this study, we obtained evidence for Bacillus subtilis that produce DNJ in large quantities by high performance liquid chromatography. Inhibition of α-glucosidase activity was determined to DNJ production or non-production. Investigation of the effect of mulberry leaves powder concentration (1~5%), using the DNJ high-production bacteria, provided evidence for microbial mass production of DNJ. When the 4% mulberry leaf powder for 9 days was used, the α-glucosidase inhibitory activity was over the 85%. Also, the results presented in this study confirm DNJ yield’s increasement in microbes using the various of nutrients and provide insight of ways to improve DNJ yields in microorganisms.
참고문헌 (31)
- Asai A, "Effect of mulberry leaf extract with enriched 1-deoxynojirimycin content on postprandial glycemic control in subjects with impaired glucose metabolism", Journal of Diabetes Investigation, 2, pp.318~323 (2011)
- Asano N, "N-containing sugars from Morus alba and their glycosidase inhibitory activities", Carbohydrate Research, 259, pp.243~255 (1994)
- Asano N, "Polyhydroxylated alkaloids isolated from mulberry trees (Morus alba L.) and silkworms (Bombyx mori L.)", J. Agric. Food Chem., 49, pp.4208~4213 (2001)
- Butters TD, "Therapeutic applications of iminosugars in lysosomal storage disorders", Current Topics in Medicinal Chemistry, 3, pp.561~574 (2003)
- 조용석, "1-Deoxynojirimycin을 생산하는 Bacillus subtilis S10 배양액의 혈당강하 효과", 한국식품영양과학회지, 37(11), pp.1401~1407 (2008), 한국식품영양과학회
- Daniel CS, , Applied and Environmental Microbiology, 48(2), pp.280~284 (1984)
- Ezure Y, "Moranoline (1-deoxynojirimycin) fermentation and its improvement", Agric. Biol. Chem., 49, pp.1119~1125 (1985)
- Frandsen TP, "Plant α-glucosidases of the glycoside hydrolase family 31. Molecular properties, substrate specificity, reaction mechanism, and comparison with family members of different origin", Plant Molecular Biology, 37, pp.1~13 (1998)
- Fujita H, "Efficacy and safety of Touchi extract, an α-glucosidase inhibitor derived from fermented soybeans, in non-insulin-dependent diabetic mellitus", Journal of Nutritional Biochemistry, 12, pp.351~356 (2001)
- Fujita H, "Long-term ingestion of Touchi-extract, an α-glucosidase inhibitor, by borderline and mild type-2 diabetic subjects is safe and significantly reduces blood glucose levels", Nutrition Research, 23, pp.713~722 (2003)
- Gruters, RA, "Interference with HIV-induced syncytium formation and viral infectivity by inhibitors of trimming glucosidase", Nature, 330, pp.74~77 (1987)
- Hardick DJ, "The biosynthesis of deoxynojirimycin and deoxymannonojirimycin in Streptomyces subrutilus", J. Chem. Soci. & Chem. Communications., 10, pp.729~730 (1991)
- Hardick D, "The biosynthesis of 1-deoxynojirimycin in Bacillus subtilis var niger", Tetrahedron, 49, pp.6707~6716 (1993)
- Holman RR, "A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years", Diabetes Care, 22, pp.960~964 (1999)
- Iwasa T, "Studies on validamycins, new antibiotic I. Streptomyces hygroscopicus var. limoneus. Validamycin producing organism", Journal of Antibiotechnology, 23, pp.595~602 (1970)
- 주완택, "Screening of 1-deoxynojirimycin (DNJ) producing bacteria using mulberry leaf", International Journal of Industrial Entomology, 31(2), pp.48~55 (2015), 한국잠사학회
- Kameda Y, "New cyclitols, degradation of validamycin A by Flavobacterium saccharophilum", Journal of Antibiotechnology, 33, pp.1573~1574 (1980)
- Kim KY, "Potent α-glucosidase inhibitors purified from the red alga Grateloupia elliptica", Phytochem., 69, pp.2820~2825 (2008)
- Kim JW, "Determination of 1-deoxynojirimycin in Morus alba L. leaves by derivatization with 9-fluorenylmethyl chloroformate followed by reversed-phase high-performance liquid chromatography", J. Chromatogr. A., 1002, pp.93~99 (2003)
- Kimura T, "Determination of 1-deoxynojirimycin in mulberry leaves using hydrophilic interaction chromatography with evaporative light scattering detection", J. Agric. Food Chem., 52, pp.1415~1418 (2004)
- Kimura T, "Food-grade mulberry powder enriched with 1-deoxynojirimycin suppresses the elevation of postprandial blood glucose in human", J. Agric. Food Chem., 55, pp.5869~5874 (2007)
- Konno K, "Mulberry latex rich in antidiabetic sugar-mimic alkaloids forces dieting on caterpillars", Proceedings of National Academy of Sciences in USA, 103, pp.1337~1341 (2006)
- McCue P, "Anti-diabetic and antihypertensive potential of sprouted and solid-state bioprocessed soybean", Asian Pacific Journal of Clinic Nutrition, 14(2), pp.145~152 (2005)
- Mehta A, "Alphaglucosidase inhibitors as potential broad based anti-viral agents", FEBS Letters, 23, pp.17~22 (1998)
- Paek NS Kang DJ, "Production of 1-deoxynojirimycin by Streptomyces sp. SID9135", J. Microbiol. Biotechnol., 7, pp.262~266 (1997)
- Schmidt DD, "α-Glucosidase inhibitors, new complex oligosaccharides of microbial origin", Naturwissenschaften, 64, pp.535~536 (1977)
- Seo MJ, "Isolation of the putative biosynthetic gene cluster of 1-Deoxynojirimycin by Bacillus amyloliquefaciens 140N, its production and application to the fermentation of soybean paste", Biosci. Biotechnol. Biochem, 77(2), pp.398~401 (2013)
- Stein DC, "Characterization of Bacillus subtilis DSM704 and its production of 1-deoxynojirimycin", Appl. Environmental. Microbiol., 48, pp.280~284 (1984)
- Vichasilp C, "A novel gelatin crosslinking method retards release of mulberry 1-deoxynojirimycin providing a prolonge hypoglycaemic effect", Food Chem., 134, pp.1823~1830 (2012)
- Zheng YG, "Production of valienamine by a newly isolated strain: Stenotrophomonas maltrophilia", Enzyme and Microbial Technology, 39, pp.1060~1065 (2006)
- Zhu YP, "Effects of sources of carbon and nitrogen on production of α-glucosidase inhibitor by a newly isolated strain of Bacillus subtilis B2", Food chemistry, 109, pp.737~742 (2008)